Results 161 to 170 of about 19,037 (201)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Chemotherapeutic experience in indeterminate cell histiocytosis

British Journal of Dermatology, 2005
R. Caputo, A.V. Marzano, E. Passoni, M. Bellinvia   +3 more
openaire   +2 more sources

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov, Marion Smits, Priscilla K Brastianos   +2 more
exaly  

Indeterminate cell histiocytosis in a Chinese patient with progressive and extensive nodular lesions and mixed indeterminate cell and macrophage‐monocyte lineage

Journal of cutaneous pathology, 2018
Qiping Chen, J. Lee, M. Liang, M. Chan, R. Pujol, L. Requena, S. Tan   +6 more
semanticscholar   +1 more source

Treatment of indeterminate cell histiocytosis with pravastatin

Journal of the American Academy of Dermatology, 2011
Molly V. Burns, Ammar Ahmed, Gabriela Blanco Callahan, Lu Q. Le, Clay Cockerell   +4 more
openaire   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

Ca-A Cancer Journal for Clinicians, 2020
Enrica Marchi
exaly  

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Ca-A Cancer Journal for Clinicians, 2015
Angela C Chi
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Photodynamic therapy of cancer: An update

Ca-A Cancer Journal for Clinicians, 2011
Patrizia M Agostinis, Kristian Berg, Keith A Cengel   +2 more
exaly